An Expanded Access Program (EAP) for OLZ/SAM in Pediatric Participants With Schizophrenia or Bipolar I Disorder (ALKS 3831-315)
Clinical trial NCT07744113 · AVAILABLE
Trial details
- NCT number
- NCT07744113
- Sponsor
- Alkermes, Inc.
- Status
- AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.